You are here

Home » Content

Diyabetes Mellituslu Hastaların Glisemik Kontrol Seviyelerine ve Kronik Komplikasyonlarına Etkili Sosyoekonomik ve Hastalık Özelliklerinin Araştırılması

Investigation of Socioeconomic and Disease Characteristics which Effect Glysemic Control Levels and Chronic Complications of Patients with Diabetes Mellitus

Journal Name:

  • Smyrna Tıp Dergisi

Publication Year:

  • 2016

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Objective: In this study, factors which effect to glysemic control levels and chronic complications of the patients with DM was investigated. Materials an d Methods: Patients' data of age, gender, education level, monthly income, smoking, living alone or living with his/her family and data about waist circumference, body mass index, type of DM, duration of DM, insülin usage and comorbidity with patients' fasting blood glucose (FBG) levels, HbAlc levels and chronic complication situations of diabetic patients were investigated. Results: In the study income of the patients whose HbA1c values were <%7 was found significantly higher than income of the patients whose HbAlc values were >%7-<%9 and >%9 (p<0,05). Insulin usage in the patients whose HbAlc values were >%9 was found significantly higher than in the patients whose HbAlc values were >%7-<%9 and <%7 (p<0,05). Income of the patients whose FBG were <130 mg/dl was found significantly higher than income of the patients whose FBG were >l30mg/dl-<200 mg/dl and >200 mg/dl (p<0,05). In treatment; only oral antidiabetic drug usage were significantly higher in the patients whose FBG were <130 mg/dl than in the patients whose FBG were >l30mg/dl-<200 mg/dl and >200 mg/dl (p<0,05). Age of the patients who have microvascular complication was significantly higher than age of the patients who do not have microvascular complication (p<0,05). Comorbidity in the patients who have microvascular complication was significantly higher than in the patients who do not have microvascular complication (p<0,05). Age of the patients who have macrovascular complication was significantly higher than the age of the patients who do not have macrovascular complication (p<0,05). Waist circumference of the patients who have macrovascular complication was significantly higher than waist circumference of the patients who do not have macrovascular complication (p<0,05). Discussion: There are different results in various studies about effective factors to glisemic control levels and chronic complications of diabetic patients. Definition of these factors is important because of its help to prevention of chronic complications, reduction of morbidity and mortalitiy and reduction of health expenditures due to DM.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Çalışmada DM'li hastaların glisemik kontrol seviyelerine ve kronik komplikasyonlarına etki eden faktörlerin araştırılması amaçlanmıştır. Gereç ve Yöntem: Çalışmada DM'li hastaların yaş, cinsiyet, eğitim durumu, aylık gelir düzeyi, sigara kullanımı, yalnız mı yoksa ailesiyle birliktemi yaşadığı bilgilerini ve bel çevresi, vücut kitle indeksi değeri, DM Tipi, DM süresi, tedavide kullanılan ilaç türü ve komorbid hastalık durumu bilgileri; hastaların açlık kan şekeri (AKŞ) düzeyleri, HbAlc seviyeleri ve kronik komplikasyon durumları ile karşılaştırılmıştır. Bulgular: ÇalışmadaHbAlc değerleri <%7olan hastaların aylık gelirleri, HbAlc değerleri >%7-<%9 olan ve >%9 olan hastalardan anlamlı olarak daha yüksek bulundu (p<0,05). HbAlc değerleri >%9 olan hastalarda insülin kullanımı, HbAlc değerleri <%7 olan ve >%7-<%9 olan hastalardan anlamlı olarak daha yüksek bulundu (p<0,05). AKŞ<130mg/dl olan hastaların aylık gelirleri, AKŞ >l30mg/dl-<200mg/dl olan ve >200mg/dl olan hastalardan anlamlı olarak daha yüksek bulundu (p<0,05). AKŞ<l30mg/dl olan hastalarda tedavide sadece oral antidiyabetik ilaç kullanımı, AKŞ >l30mg/dl-<200mg/dl olan ve >200mg/dl olan hastalardan anlamlı olarak daha yüksek bulundu (p<0,05). Mikrovasküler komplikasyonu olan hastaların yaşı anlamlı olarak daha yüksekti (p<0,05). Mikrovasküler komplikasyonu olan hastalarda comorbid hastalık olması anlamlı olarak daha yüksekti (p<0,05). Makrovasküler komplikasyonu olan hastaların yaşı anlamlı olarak daha yüksekti (p<0,05). Makrovasküler komplikasyonu olan hastaların bel çevreleri anlamlı olarak daha yüksek olarak bulundu (p<0,05). Sonuç: Diyabetli hastaların glisemik kontrol seviyelerine ve kronik komplikasyonlarına etkili faktörler hakkındaki çeşitli yayınlarda birbirinden farklı sonuçlar mevcuttur. Bu faktorlerin tanımlanması, diyabetin kronik komplikasyonlarının önlenmesine, diyabete bağlı morbidite ve mortalitenin azalmasına ve sağlık harcamalarının azalmasına yardımcı olacağı için önemlidir.
FULL TEXT (PDF): 
PDF icon arastirmax-diyabetes-mellituslu-hastalarin-glisemik-kontrol-seviyelerine-kronik-komplikasyonlarina-etkili-sosyoekonomik-hastalik-ozelliklerinin-arastirilmasi.pdf
  • 1
18
26
  • Turkish

REFERENCES

References: 

1. Braunwald E. Harrison's Principles of Internal Medicine, Çeviri Eds. Biberoğlu K. l7. Baskı. İstanbul, Nobel Tıp Kitabevi, 20l3;2275-7.
2. International Diabetes Federation. Online version of IDF Diabetes Atlas, 6th Edition. 2013;11-3.
3. Satman I, Yilmaz T, Sengül A, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25(9):1551-6.
4. Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28(2):169-80.
5. The Diabetes Control and Complications Trial Research Group, The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-term Complications in Insulin-dependent Diabetes Mellitus. N Engl J Med 1993;329:977-86.
6. American Diabetes Association: Standards of Medical Care in Diabetes-2009, Diabetes Care
2009;32(1):13-61.
7. Standards of Medical Care in Diabetes, Diabetes
Care 2006;29:4-42.
8.
Güncel Tıbbi Tanı ve Tedavi 20l0, Eds. Müftüoğlu E. 49. Baskı. Adana, Nobel Kitabevi,
2010;1104-8.
9. American Diabetes Association. Economic Costs of Diabetes in the US in 2007. Diabetes Care 2008;31:596-615.
10. Zhuo X, Zhang P, Hoerger TJ. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med
2013;45(3):253-61.
11. Lee CM, Colagiuri R, Magliano DJ, et al. The
cost of diabetes in adults in Australia. Diabetes
Res Clin Pract 2013;99(3):385-90.
Smyrna
Tıp Dergisi -26-
12. Erdogan G, Güllü S, Erdogan MF, et al.
Influence of patient education on glycemic control in diabetic patients. Turkish Journal of Endocrinology and Metabolism 1998;2:101-4.
13. Ali MK, McKeever BK, Imperatore G,et al. Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes. National Health and Nutrition Examination Survey, United States, 2007-2010. MMWR Morb Mortal Wkly Rep
2012;61:32-7.
14. Kim HY, Yun WJ, Shin MH, et al. Management of Diabetic Mellitus in Low-income Rural Patients. J Prev Med Public Health 2009;42(5):315-22.
15. Weinstock RS, Teresi JA, Goland R et al. IDEATel Consortium. Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine
(IDEATel) study. Diabetes Care 2011;34(2):274-9.
16. Hansen LJ, Olivarius N de F, Siersma V et al. Individualised treatment goals in diabetes care. Scand J Prim Health Care 2004;22(2):71-7.
17. Perez A, Franch J, Cases A, et al. Relationship between the degree of glycemic control and diabetes characteristics and hyperglycemia treatment in type 2 diabetes. DIABES Study, Med Clin (Barc). 2012;138(12):505-11.
18. Bawadi HA, Banks AD, Ammari F, et al. Stage of change of 6 health-related behaviors among patients with type 2 diabetes, Prim Care Diabetes 2012;6(4) :319-27.
19. Gutierrez GA, Playân Usön J, Rubio Aranda E, et al. Effect of the smoking habit on carbohydrate metabolism. An Med Interna
1993;10(12):583-6.
20. Ko KD, Kim BH, Oh SI, et al. What are patient
factors associated with the quality of diabetes care?: results from the Korean National Health and Nutrition Examination Survey. BMC Public
Health 2012;12(1):689.
21. Naranjo DM, Jacobs EA, Fisher L, et al. Age and Glycemic Control Among Low-Income
Latinos, J Immigr Minor Health 2013;15(5):898-902.
22. Ghazanfari Z, Niknami S, Ghofranipour F, et al. Determinants of glycemic control in female diabetic patients: a study from Iran. Lipids
Health Dis 2010;9:83.
23. Goya K, Kitamura T, Inaba M, et al. Risk factors for asymptomatic atherosclerosis in Japanese type 2 diabetic patients without diabetic microvascular complications.
Metabolism 2003;52(10):1302-6.
24. Chillarön JJ, Sales MP, Sagarra E, et al. Chronic complications in type 1 diabetes mellitus. Analysis of a cohort of 291 patients
with a mean evolution time of 15 years. Rev Clin
Esp 2012;212(8):375-82.

Thank you for copying data from http://www.arastirmax.com